Document is current
Any future updates will be listed below
-
Authors
Zhao, Yue
Herrera-Caceres, Jaime O.
Nobes, Jennifer
Lyu, ZiCheng
Vetter, Marcus
Falandry, Claire
Goede, Valentin
Neuendorff, Nina Rosa
Loh, Kah Poh
Canin, Beverly
Wildiers, Hans
Battisti, Nicolò Matteo Luca
- License Information
-
More Information
Article History
Received: 2 April 2025
Accepted: 12 January 2026
First Online: 5 February 2026
Competing interests
: N.M.L.B. declares the following competing interests: Advisory board: Pfizer, Abbott, Sanofi, Astellas, Merck; travel grants: Exact Sciences, Pfizer, Lilly, Novartis; speaker fees: Pfizer, AbbVie, Roche, Sanofi, Novartis, Servier, Gilead, AstraZeneca, Lilly, Exact Sciences. V.G. declares the following competing interests: Advisory Board/Speaker Fee: AstraZeneca, AbbVie, Merck, Novartis, Norgine, Berlin Chemie. M.V. declares the following competing interests: Advisory Boards: Pfizer, Novartis, AstraZeneca; Industry grants: GSK, AstraZeneca, AbbVie, Roche, ExactSciences; Travel Grants: Novartis, Roche, Lilly. N.R.N. has received honoraria and travel support from Janssen-Cilag, Medac, Novartis, Pfizer, AbbVie, Hexal, and Jazz Pharmaceuticals. The remaining authors declare that they have no competing interests.
